EBER is able to trigger an inflammatory response through the toll-like receptor (TLR) pathway, leading to elevated levels of tumor necrosis factor α (TNF-α), and synergies with LMP1 through a positive feedback loop mediated by NF-κB to amplify the inflammatory response in NPC [127]. The gene discussed is NFKB1; the disease is nasopharyngeal carcinoma.